MLive1d
What parents of young children should know about RSV, including ‘new armor’
Respiratory syncytial virus, or RSV, typically presents as mild, with symptoms similar to the common cold for adults and ...
Allure on MSN1d
Everything You Need to Know About the 2024 RSV Season
Experts share the official predictions for RSV surge levels in 2024 and 2025, why the levels change each year, and how to ...
Medpage Today on MSN4d
FDA Expands Approval of RSV Vaccine Abrysvo to Include All At-Risk Adults
The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower ...
FiercePharma1d
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...
Seniors Shielded: New RSV Vaccine Shows 80% Effectiveness
Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...
ENDPOINTS NEWS2d
CDC ad­vi­sors de­cline to rec­om­mend RSV shots to younger at-risk adults, af­firm­ing pri­or guid­ance
The CDC's vaccine policy advisors haven't budged on new RSV guidance, remaining unconvinced that younger adults at higher ...
FiercePharma2d
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...
fox13now2d
A 'gamechanger' in the fight against RSV
Important information new parents need to know about Respiratory Syncytial Virus, or RSV. It comes around when the weather ...
Doctors urge families to protect babies, older adults as RSV immunizations now in supply: HealthLink
Expecting mothers in their 32nd to 36th week of pregnancy can get an RSV vaccine, which will pass along antibodies to their newborn. Or, babies up to eight months old, can get a monoclonal antibody ...
Study confirms RSV vaccine's protective power for seniors
A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...
BioPharma Dive3d
Pfizer’s RSV vaccine cleared by FDA for use in some younger adults
Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people ...
Free RSV vaccinations slashed hospital presentations of babies and infants
Fewer babies were hospitalised with Respiratory Syncytial Virus (RSV) this year due to the success of free vaccinations in WA ...